menu search

Phathom pharmaceuticals presents new data at digestive disease week® (ddw) 2023

Higher H. pylori eradication rates demonstrated with vonoprazan-based regimens vs. lansoprazole triple therapy, regardless of different baseline demog...

May 9, 2023, 12:00 pm

Verrica pharmaceuticals reports first quarter 2023 financial results

New Drug Application for YCANTH™ (VP-102) PDUFA Goal Date of July 23, 2023 – Potential to Become Only FDA-approved Therapy for Treatment of Mollus...

May 9, 2023, 11:30 am

Arbutus to present at jmp securities life sciences conference

WARMINSTER, Pa., May 09, 2023 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage...

May 9, 2023, 11:30 am

Wall street analysts predict a 42.46% upside in agios pharmaceuticals (agio): here's what you should know

The consensus price target hints at a 42.5% upside potential for Agios pharmaceuticals (AGIO). While em...

May 9, 2023, 11:27 am

Atossa therapeutics to present insights from ongoing evangeline clinical trial at asco annual meeting

Atossa Therapeutics, Inc has announced that it will present a Trial in Progress poster for the Phase 2 clinical study of (Z)-endoxifen in premenopausa...

May 9, 2023, 10:23 am

Spectrum pharmaceuticals (sppi) reports q1 loss, tops revenue estimates

Spectrum pharmaceuticals (SPPI) came out with a quarterly loss of $0.02 per share versus the Zacks Cons...

May 9, 2023, 9:56 am

Tscan therapeutics stock soars after amgen collaboration on crohn's disease treatment that could bring in more than $500 million

Shares of TScan Therapeutics Inc. TCRX powered up 43.1% in premarket trading Tuesday, after the biopharmaceuti...

May 9, 2023, 9:15 am

Commodity chemicals market to witness growth at a 6.60% cagr – report by market research future (mrfr)

Commodity Chemicals Market Research Report Information By Product (Ester, Ether, Amine, Alcohol, Ketones, Fatty Chemicals, Chelating Agents and Others...

May 9, 2023, 8:47 am

Fusion pharmaceuticals to present at the guggenheim healthcare talks radiopharmaceuticals day

HAMILTON, ON and BOSTON , May 9, 2023 /PRNewswire/ -- Fusion pharmaceuticals Inc. (Nasdaq: FUSN), a cl...

May 9, 2023, 7:45 am

Ionis to present at upcoming investor conferences

CARLSBAD, Calif. , May 9, 2023 /PRNewswire/ -- Ionis pharmaceuticals, Inc. (Nasdaq: IONS) today announc...

May 9, 2023, 7:05 am

Nextcure to present at the jmp securities life sciences conference

BELTSVILLE, Md., May 09, 2023 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceu...

May 9, 2023, 7:00 am

Syndax pharmaceuticals, inc. (sndx) q1 2023 earnings call transcript

Syndax pharmaceuticals, Inc. (NASDAQ:SNDX ) Q1 2023 Earnings Conference Call May 8, 2023 4:30 PM ET Com...

May 8, 2023, 10:53 pm

Quoin pharmaceuticals provides corporate update and announces first quarter 2023 financial results

First patient dosed in Quoin’s single arm, open label clinical trial in Netherton Syndrome patients currently receiving off-label systemic therapy R...

May 8, 2023, 9:00 pm

Atea pharmaceuticals, inc. (avir) q1 2023 earnings call transcript

Atea pharmaceuticals, Inc. (NASDAQ:AVIR ) Q1 2023 Results Conference Call May 8, 2023 4:30 PM ET Compan...

May 8, 2023, 8:51 pm

Acadia pharmaceuticals inc. (acad) q1 2023 earnings call transcript

ACADIA pharmaceuticals Inc. (NASDAQ:ACAD ) Q1 2023 Earnings Conference Call May 8, 2023 4:30 PM ET Comp...

May 8, 2023, 8:03 pm

Enanta pharmaceuticals (enta) reports q2 loss, misses revenue estimates

Enanta pharmaceuticals (ENTA) came out with a quarterly loss of $1.79 per share versus the Zacks Consen...

May 8, 2023, 7:03 pm

Acadia pharmaceuticals (acad) reports q1 loss, lags revenue estimates

Acadia pharmaceuticals (ACAD) came out with a quarterly loss of $0.27 per share versus the Zacks Consen...

May 8, 2023, 7:02 pm

Johnson & johnson (jnj) shares are entering in a bull trap

Johnson & Johnson (JNJ) is an American multinational corporation founded in 1886 that develops medical devices, ...

May 8, 2023, 5:32 pm

Carisma therapeutics to present at the jmp securities life sciences conference

PHILADELPHIA , May 8, 2023 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage bio...

May 8, 2023, 4:30 pm

Ligand (lgnd) up 3% on raised '23 view, beats on q1 earnings

Ligand pharmaceuticals (LGND) announces better-than-expected results in first-quarter 2023. Management ...

May 8, 2023, 1:43 pm


Search within

Pages Search Results: